MBRX
USDMoleculin Biotech Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$0.483
Máximo
$0.502
Mínimo
$0.470
Volumen
2.28M
Fundamentos de la Empresa
Capitalización de Mercado
24.6M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
4.00M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia "MIRACLE" Clinical Trial at the 14th Annual Acute Leukemia Meeting
HOUSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
Atlantic Health, a leading provider of health care based in New Jersey, to conduct the investigator-initiated Phase 1B/2 study Preclinical studies indicate Annamycin targets key factors in pancreatic cancer HOUSTON,
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity InsiderNews Commentary – Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms,...
Acciones Relacionadas
AGNCN
AGNC Investment Corp. Depositary Shares Each Representing a 1/1000th Interest in a Share of 7.00% Series C Fixed-To-Floating Rate Cumulative Redeemable Preferred Stock
SEVN
Seven Hills Realty Trust
NXN
Nuveen New York Select Tax-Free Income Portfolio
SQ
Block Inc.
SPKLW
Spark I Acquisition Corp. Warrant
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.